Medicare’s Insulin Demo Project Likely Depends On Plan Interest
Executive Summary
Manufacturers are on board for ‘Part D Senior Savings Model’ that would set a $35 copay cap, but added risk corridor payments may be the key to getting PBMs to offer the enhanced plans focused on reducing insulin costs for patients.
You may also be interested in...
US Medicare Insulin Demo Could Expand To Other Drugs
Eighty-eight insurers who offer Medicare Part D plans are interested in the demonstration project, which would limit insulin copays to $35.
US Medicare Insulin Demo Could Expand To Other Drugs
Eighty-eight insurers who offer Medicare Part D plans are interested in the demonstration project, which would limit insulin copays to $35.
Medicare Plan For Lowering Insulin Costs Takes Aim At Benefit Design Instead Of List Prices
The new payment demonstration in Part D reflects the increasing recognition that insurance benefit design has a major impact on insulin affordability.